光热治疗
癌细胞
TRPV1型
纳米载体
瞬时受体电位通道
细胞凋亡
生物物理学
化学
纳米医学
细胞
癌症
癌症研究
细胞生物学
药物输送
纳米技术
材料科学
受体
纳米颗粒
医学
生物化学
生物
内科学
作者
Zhen J. Xu,Chen Xie,Yuyan Jiang,Xiangzhao Ai,Bengang Xing,Kanyi Pu
出处
期刊:Nano Letters
[American Chemical Society]
日期:2018-01-17
卷期号:18 (2): 1498-1505
被引量:221
标识
DOI:10.1021/acs.nanolett.7b05292
摘要
Nanomedicine have shown success in cancer therapy, but the pharmacological actions of most nanomedicine are often nonspecific to cancer cells because of utilization of the therapeutic agents that induce cell apoptosis from inner organelles. We herein report the development of semiconducting photothermal nanoagonists that can remotely and specifically initiate the apoptosis of cancer cells from cell membrane. The organic nanoagonists comprise semiconducting polymer nanoparticles (SPNs) and capsaicin (Cap) as the photothermally responsive nanocarrier and the agonist for activation of transient receptor potential cation channel subfamily V member 1 (TRPV1), respectively. Under multiple NIR laser irradiation at the time scale of seconds, the nanoagonists can repeatedly and locally release Cap to multiply activate TRPV1 channels on the cellular membrane; the cumulative effect is the overinflux of ions in mitochondria followed by the induction of cell apoptosis specifically for TRPV1-postive cancer cells. Multiple transient activation of TRPV1 channels is essential to induce such a cell death both in vitro and in vivo because both free Cap and simple Cap-encapsulated nanoparticles fail to do so. The photothermally triggered release also ensures a high local concentration of the TRPV1 agonist at tumor site, permitting specific cancer cell therapy at a low systemic administration dosage. Our study thus demonstrates the first example of ion-channel-specific and remote-controlled drug-delivery system for cancer cell therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI